Zollinger‑Ellison syndrome – gastrinoma associated with Carney’s triad - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Zollinger‑Ellison Syndrome – Gastrinoma Associated with Carney’s Triad

Zollinger‑Ellison Syndrome – Gastrinoma Associated with Carney’s Triad

Overview

Zollinger‑Ellison syndrome (ZES) is a rare disorder in which one or more gastrin‑producing tumors (gastrinomas) cause excessive stomach acid secretion. When these gastrinomas occur as part of Carney’s triad—the combination of gastric stromal tumor (GIST), pulmonary chondroma, and extra‑adrenal paraganglioma—the condition is especially uncommon. Carney’s triad predominantly affects young women, while isolated ZES can affect any adult.

  • Prevalence of ZES: Approximately 0.5–2 cases per million people worldwide.1
  • Prevalence of Carney’s triad: Fewer than 200 cases reported in the literature; >90 % are female, with a median age of diagnosis around 20 years.2
  • Age & gender: Isolated ZES peaks at 40–60 years; Carney‑related ZES occurs mainly in females aged 10–30.

Symptoms

Because ZES results in an over‑production of gastric acid, the clinical picture is dominated by ulcer‑related complaints, but patients with Carney’s triad may have additional features from the other tumors.

Gastrinoma‑related symptoms

  • Refractory peptic ulcers – often multiple, located in the duodenum or distal jejunum.
  • Abdominal pain – burning or gnawing, worsening 1–2 hours after meals.
  • Diarrhea – caused by acid inactivation of pancreatic enzymes; can be watery, fatty or steatorrhea.
  • Heartburn / gastro‑esophageal reflux disease (GERD).
  • Nausea & vomiting – sometimes with blood if ulcer erodes.
  • Weight loss – secondary to malabsorption and chronic pain.
  • Gastrointestinal bleeding – melena or hematemesis from ulcer erosion.

Symptoms related to Carney’s triad

  • GIST (gastric stromal tumor) – may cause early satiety, vague fullness, or be asymptomatic.
  • Pulmonary chondroma – cough, chest discomfort, or incidental finding on imaging.
  • Extra‑adrenal paraganglioma – episodic hypertension, palpitations, headache, or diaphoresis.

Causes and Risk Factors

ZES is a neuroendocrine tumor condition. The majority are sporadic, but 20–30 % are linked to the inherited MEN1 (multiple endocrine neoplasia type 1) syndrome. Carney’s triad is not inherited in a classic Mendelian fashion; the exact cause remains obscure, though somatic mutations in the SDH (succinate dehydrogenase) gene complex have been implicated.

  • Genetic factors: MEN1 mutation (chromosome 11q13) increases risk for gastrinomas; SDH subunit mutations (especially SDHB, SDHC, SDHD) are seen in Carney’s triad.
  • Age: Sporadic ZES usually appears after 40 y; Carney’s triad appears in teens‑20s.
  • Sex: Carney’s triad strongly female‑predominant (≈9 : 1). Sporadic ZES has no clear gender bias.
  • Family history: A first‑degree relative with MEN1 or ZES raises suspicion.
  • Environmental: No specific lifestyle or environmental risk has been proven.

Diagnosis

Diagnosis requires a combination of biochemical, imaging, and sometimes histologic studies.

Biochemical testing

  • Fasting serum gastrin level: >1000 pg/mL (10 ×  ULN) is highly suggestive. Levels 200–1000 pg/mL require a provocative secretin stimulation test.
  • Secretin stimulation test: In ZES, gastrin paradoxically rises >120 pg/mL after IV secretin (0.4 U/kg).
  • Acid output measurement (optional): Gastric acid >15 mEq/h confirms hypersecretion.

Imaging studies

  • Contrast‑enhanced CT scan of the abdomen/pelvis: First‑line to locate gastrinomas (pancreas, duodenum, lymph nodes).
  • Somatostatin receptor scintigraphy (SRS) / Ga‑68 DOTATATE PET‑CT: Highly sensitive (≈90 %) for neuroendocrine tumors and detects occult lesions.
  • Endoscopic ultrasound (EUS): Excellent for small pancreatic head lesions (<2 cm).
  • Upper endoscopy (EGD): Identifies ulcer burden; biopsies rule out H. pylori or malignancy.
  • Chest CT** (when Carney’s triad is suspected) to evaluate pulmonary chondromas.

Pathology (rarely needed)

If surgery is performed, the tumor is examined for neuroendocrine markers (chromogranin A, synaptophysin) and Ki‑67 index to grade aggressiveness.

Treatment Options

Management combines acid suppression, tumor control, and surveillance.

Medical therapy – controlling acid hypersecretion

  • High‑dose proton pump inhibitors (PPIs) (e.g., omeprazole 60–120 mg/day, or equivalent). PPIs normalize gastric pH in >90 % of patients.3
  • Histamine‑2 receptor antagonists are less effective and usually used only when PPIs are contraindicated.
  • Life‑long therapy is often required; dose titration based on symptom control and gastrin levels.

Surgical options – removing the gastrinoma

  • Localized disease: Enucleation or pancreaticoduodenectomy (Whipple) for pancreatic head lesions; duodenal lesions may be excised via transduodenal approach.
  • Metastatic disease: Cytoreductive surgery plus hepatic resection if liver metastases are resectable.
  • Debulking surgery can reduce acid load and improve PPI responsiveness.

Medical therapy for tumor control

  • Somatostatin analogues (octreotide LAR 30 mg IM q28 days or lanreotide) suppress gastrin secretion and may stabilize tumor growth.
  • Targeted therapy: Sunitinib or everolimus for progressive, unresectable neuroendocrine tumors (based on NET guidelines).
  • Chemotherapy is rarely required; used for high‑grade (G3) neuroendocrine carcinoma.

Treatment specific to Carney’s triad

  • GIST: Surgical resection; imatinib is used only for metastatic or unresectable disease (most GISTs in Carney’s triad are KIT‑negative, limiting imatinib efficacy).
  • Pulmonary chondroma: Observation unless symptomatic; surgical resection for large or growing lesions.
  • Paraganglioma: Surgical excision; pre‑operative α‑blockade if catecholamine‑secreting.

Lifestyle & supportive care

  • Avoid NSAIDs, aspirin, and smoking – they increase ulcer risk.
  • Small, frequent meals reduce acid‑triggered pain.
  • Calcium and vitamin D supplementation if long‑term PPI therapy leads to hypocalcemia.

Living with Zollinger‑Ellison Syndrome – Gastrinoma Associated with Carney’s Triad

Managing a chronic rarity can be overwhelming. Below are practical tips to help patients stay in control.

  • Medication adherence: Keep a daily pill organizer; set alarms for PPIs and somatostatin analogues.
  • Regular monitoring: Check fasting gastrin levels annually or sooner if symptoms change; repeat imaging (CT/MRI) every 1–2 years.
  • Nutrition: Emphasize low‑fat, high‑protein foods; consider dietitian referral for malabsorption issues.
  • Vaccinations: Patients on long‑term PPIs have higher risk of C. difficile; stay up to date on flu, pneumococcal, and COVID‑19 vaccines.
  • Psychosocial support: Connect with rare‑disease patient groups (e.g., Carney’s Triad Foundation) and mental‑health professionals.
  • Pregnancy considerations: PPIs are generally safe; discuss tumor surveillance with obstetrics & endocrinology.
  • Emergency plan: Carry a card summarizing diagnosis, current meds, and contact numbers for your specialist team.

Prevention

Because ZES and Carney’s triad are largely driven by genetic or sporadic mutations, primary prevention is limited. However, risk can be mitigated by:

  • Early screening of at‑risk family members (MEN1 mutation carriers) with fasting gastrin tests and abdominal imaging.
  • Eradicating Helicobacter pylori infection, which can exacerbate ulcer disease.
  • Avoiding chronic use of acid‑damaging medications (NSAIDs, high‑dose steroids) unless medically necessary.

Complications

If untreated or inadequately controlled, ZES can lead to serious health problems.

  • Refractory or perforated peptic ulcers – may require emergency surgery.
  • Gastrointestinal bleeding – can cause anemia, requiring transfusion.
  • Gastro‑esophageal strictures – from chronic acid injury.
  • Malnutrition & electrolyte disturbances (e.g., hypokalemia from chronic diarrhea).
  • Metastatic neuroendocrine carcinoma – occurs in ~10–20 % of gastrinomas; liver is the most common site.
  • Carney’s triad‑related complications: GIST rupture, pulmonary chondroma growth causing airway obstruction, paraganglioma hypertensive crises.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience any of the following:
  • Sudden, severe abdominal pain that does not improve with medication.
  • Vomiting blood (bright red) or material that looks like coffee grounds.
  • Black, tarry stools (melena) or sudden weakness/fainting suggestive of major bleeding.
  • Sudden onset of high‑grade fever (>38.5 °C) with abdominal tenderness – possible perforated ulcer.
  • Rapid heart rate, severe hypertension, sweating, and headache – signs of a catecholamine‑secreting paraganglioma crisis.
  • Any new neurologic symptoms (confusion, seizures) in the setting of severe electrolyte loss.

Sources:

  1. Mayo Clinic. “Zollinger-Ellison syndrome.” Updated 2023. https://www.mayoclinic.org
  2. Carney Triad Registry. “Clinical characteristics of Carney’s triad.” Journal of Clinical Endocrinology & Metabolism, 2022.
  3. NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Zollinger-Ellison syndrome treatment.” 2024.
  4. World Health Organization. “Neuroendocrine Tumors – Classification and Management.” 2023.
  5. Cleveland Clinic. “Somatostatin analogues for neuroendocrine tumors.” 2024.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References